Your browser doesn't support javascript.
loading
The implications of the use of cannabidiol-related products in a safety-sensitive drug testing environment: A medical-legal perspective.
Jooste, J; Laurens, J B; Jordaan, M; Marais, A A S; Curlewis, L G.
Affiliation
  • Jooste J; Department of Chemistry, Faculty of Agriculture and Natural Sciences, University of Pretoria, South Africa. jessiejooste@gmail.com.
S Afr Med J ; 111(10): 942-945, 2021 10 05.
Article in En | MEDLINE | ID: mdl-34949286
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Dronabinol / Cannabidiol / Drug and Narcotic Control Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: S Afr Med J Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Dronabinol / Cannabidiol / Drug and Narcotic Control Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: S Afr Med J Year: 2021 Document type: Article